IP Verse

Konig Szynka Tilmann Von Renesse patent opposition analysis

Get complete Patent Opposition Report for Konig Szynka Tilmann Von Renesse

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Konig Szynka Tilmann Von Renesse

Explore patent oppositions filed by Konig Szynka Tilmann Von Renesse against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP4108782	Compositions And Methods For Analyte Detection	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	Mar 7, 2024
EP3265122	Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer	EISAI R&D MANAGEMENT	Jan 23, 2023
EP3827845	Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses	JANSSEN BIOTECH	Dec 27, 2022
EP3763820	Retroviral Transduction Using Poloxamers	HELMHOLTZ ZENTRUM MNCHEN DEUTSCHES FORSCHUNGSZENTRUM FR GESUNDHEIT UND UMWELT	Sep 22, 2022
EP3521422	Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same	BAXALTA	Jul 6, 2022
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	MERCK SHARP & DOHME	Jun 1, 2022
EP3047013	Methods And Systems For Processing A Cell Culture	GENZYME	May 18, 2022
EP3440329	Fuel Exchange System And Fuel Supply System For Fuel Systems	BEFINAL	Nov 17, 2021
EP3218406	Binding Molecules Specific For Cd73 And Uses Thereof	MEDIMMUNE	Nov 12, 2021
EP3616720	Pharmaceutical Composition For Cancer Treatment	OSAKA UNIVERSITY	Oct 14, 2021

Top competitors of Konig Szynka Tilmann Von Renesse

MERCK SHARP & DOHME

CUREVAC

AMGEN